[The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].

Orv Hetil

Klinikai Immunológiai Tanszék, Debreceni Egyetem, Klinikai Központ Debrecen, Móricz Zs. út 22., 4032.

Published: April 2016

Introduction: In idiopathic inflammatory myopathies, the presence of anti-Jo-1 antibody defines a distinct clinical phenotype (myositis, arthritis, interstitial lung disease, Raynaud's phenomenon fever, mechanic's hands), called antisynthetase syndrome.

Aim: To determine the demographic data as well as clinical, laboratory and terapeutical features of anti-Jo1 positive patients, followed by the department of the authors.

Method: The medical records of 49 consecutive anti-Jo1 patients were reviewed.

Results: Demographic and clinical results were very similar to those published by other centers. Significant correlation was found between the anti-Jo-1 titer and the creatine kinase and C-reactive protein levels. Distinct laboratory results measured at the time of diagnosis of the disease (C-reactive protein, antigen A associated with Sjogren's syndrome, positive rheumatoid factor), and the presence of certain clinical symptoms (fever, vasculitic skin) may indicate a worse prognosis within the antisyntetase positive patient group.

Conclusion: In the cases above more agressive immunosuppressive therapy may be required.

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2016.30400DOI Listing

Publication Analysis

Top Keywords

anti-jo1 positive
8
c-reactive protein
8
[the shades
4
shades anti-jo1
4
positive
4
positive antisynthetase
4
antisynthetase syndrome
4
syndrome hungarian
4
hungarian cohort]
4
cohort] introduction
4

Similar Publications

Objectives: Idiopathic inflammatory myopathies (IIM) are a diverse group of muscle diseases often complicated by interstitial lung disease (ILD), which significantly impacts morbidity and mortality. Krebs von den Lungen-6 (sKL-6) has been proposed as a biomarker for ILD severity. Nailfold videocapillaroscopy (NVC) detects microvascular changes, but its diagnostic and prognostic value in IIM remains unclear.

View Article and Find Full Text PDF

Pulmonary manifestations of the idiopathic inflammatory myopathies in a South African population.

Afr J Thorac Crit Care Med

October 2024

Department of Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Article Synopsis
  • Pulmonary complications are a significant health issue for patients with idiopathic inflammatory myopathies (IIMs) in South Africa, causing high morbidity and mortality rates.
  • A study reviewed clinical records of adult IIM patients with respiratory issues in a tertiary care facility, revealing that most patients suffered from dermatomyositis and exhibited symptoms like dyspnoea and dry cough.
  • Interstitial lung disease (ILD) emerged as the most common complication, with associations found between respiratory symptoms and poorer lung function outcomes over time.
View Article and Find Full Text PDF

[Clinical associations of anti-Jo1 antibodies in a Moroccan population].

Ann Biol Clin (Paris)

November 2024

Laboratoire d'Immunologie, Centre de Recherche Clinique, CHU Mohammed VI, Marrakech, Maroc, Laboratoire de Recherche en Biosciences, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Maroc.

Anti-Jo1 antibodies are usually known markers of myositis. However, they can be associated with different pathologies. We aimed to determine the immuno-clinical characteristics of patients with positive anti-Jo1.

View Article and Find Full Text PDF

Purpose Of Review: This review aims to provide an update on myositis autoantibody testing strategies. We have focussed on the reliability and usefulness of different myositis autoantibody detection methods, including commonly used solid phase immunoassays and newer discovery techniques.

Recent Findings: Several studies have highlighted the limitations of currently available immunoassays, particularly when used in populations with low pretest probability and without supporting clinical evidence.

View Article and Find Full Text PDF

Introduction: Anti-SSA antibodies target two unrelated proteins, Ro52 (E3 ligase) and Ro60 (RNA binding protein). Previous studies indicate that anti-Ro52 antibodies are frequently associated with various myositis-specific autoantibodies (MSAs)-including anti-tRNA synthetase antibodies-and that the coexistence of MSAs and anti-Ro52 antibodies may portend worse clinical outcomes. Although not well-described in the setting of myositis, work from our animal model of HRS (histidyl-tRNA synthetase)-induced myositis suggests that anti-Ro60 antibodies may also be linked to specific MSAs such as anti-HRS/Jo-1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!